MRS allows non-invasive follow-up of treated glioblastomas tumors. There is a large variability, but repetition and modelisation of spectroscopic measurements during longitudinal follow-up could allow us to diminish it and to improve prognostic evaluation especially in long survivors and patients with proliferation relapses. Studying the relationship between MRS measures, segmentation and perfusion parameters could lead to better understanding of tumoral processes and of therapeutic response, especially with regard to chemotherapy, radiotherapy and antiangiogenic molecules and in the future oxidative stress and hypoxia modulators.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords